Skip to main content
. 2024 Aug 25;16(1):2392875. doi: 10.1080/19490976.2024.2392875

Figure 1.

Figure 1.

Flowchart of participant enrolment and eligibility.

EGCG+RES, epigallocatechin-3-gallate + resveratrol; PLA, placebo.